The 9-valent human papillomavirus (HPV) vaccine (9vHPV) is a vaccine used in the management and prevention of infection with human papillomavirus (HPV) types 6, 11, 16, 18, 31, 33, 45, 52, 58. It is in the immunization class of medications. This activity reviews the indications, action, and contraindications for the 9-valent human papillomavirus (HPV) vaccine (9vHPV) as a valuable agent in managing and preventing HPV infection and HPV-associated diseases. In addition, this activity will highlight the mechanism of action, adverse event profile, and other key factors of the 9-valent human papillomavirus (HPV) vaccine (9vHPV) administration pertinent for healthcare team members the management of patients with HPV immunization.

**Objectives:**
- Identify the mechanism of action of the 9-valent human papillomavirus vaccine (9vHPV). 
- Describe the adverse events associated with the 9-valent human papillomavirus vaccine (9vHPV).
- Explain the importance of appropriate monitoring for patients on the 9-valent human papillomavirus vaccine (9vHPV). 
- Summarize some interprofessional team strategies for improving care coordination and communication to advance the 9-valent human papillomavirus vaccine (9vHPV) immunization efforts.